Description

Linovio-D

• Increases insulin secretion and decrease glucagon secretion, helps to lower blood sugar levels. Biopharm.
  Drug Dispos 2017-38,273-270
• Selectively inhibits SGLT-2, promotes the excretion of excess glucose through the urine, thus lowers blood sugar levels with beneficial effects on the cardiovascular system. Cures 2017 Dot 5,9/10×1751, Crauletion 2016, 130 762-772
• The combined use of dapagliflozin and linagliptin is safe and tolerable.